Trial of RNActive®-Derived Cancer Vaccine and Local Radiation in in Stage IV Non Small Cell Lung Cancer (NSCLC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by CureVac GmbH
Information provided by (Responsible Party):
CureVac GmbH Identifier:
First received: July 18, 2013
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)
No publications provided by CureVac GmbH

Publications automatically indexed to this study by Identifier (NCT Number):